| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALIM | Restricted Stock Units | Award | $0 | +75K | $0.00 | 75K | Mar 11, 2024 | Common Stock | 75K | Direct | F1, F3 | ||
| transaction | ALIM | Performance-Based Restricted Stock Units | Award | $0 | +75K | $0.00 | 75K | Mar 11, 2024 | Common Stock | 75K | Direct | F2, F4 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit (RSU) represents a contingent right to receive one (1) share of the common stock of the Issuer. |
| F2 | Each Performance-Based Restricted Stock Unit (PSU) represents a contingent right to receive one (1) share of the common stock of the Issuer, subject to the achievement of applicable performance criteria. |
| F3 | The RSUs were awarded to the Reporting Person under the Alimera Sciences, Inc. 2024 Equity Inducement Plan. 25% of the RSUs are scheduled to vest on the first anniversary of the Reporting Person's employment commencement date and the remaining portion of the RSUs will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous employment with the Issuer on each such vesting date. |
| F4 | The PSUs were awarded to the Reporting Person under the Alimera Sciences, Inc. 2024 Equity Inducement Plan. Each PSU represents the right to receive, following vesting, one (1) share of common stock of the Issuer. 1/3 of the PSUs will vest for each performance year during the 3-year performance period beginning January 1, 2024 and ending on December 31, 2026 if either one of the pre-established annual revenue target and stock price target is satisfied during such performance year, as set forth in the Reporting Person's award agreement. The number of PSUs reported reflects the maximum number of PSUs that the Reporting Person may earn at the end of the 3-year performance period. |